查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1391170

2024 年药物筛选全球市场报告

Drug Screening Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药物筛选的市场规模迅速扩大。将从2023年的76.5亿美元扩大到2024年的87.9亿美元，复合年增长率为14.9%。实绩期间的成长是由于药物测试、医疗和临床诊断、药物滥用治疗、研发投资以及药物检测套组和设备的使用增加所推动的。

药物筛选市场的成长预计将受到药物和酒精消费量增加的推动。毒瘾是病理，导致无法控制合法或非法物质（如酒精、大麻或尼古丁）的使用。随着药物和酒精成瘾的增加，相关的健康风险也随之增加，因此需要进行药物筛检。 2022 年，全球对毒品和酒精消费的担忧依然存在，国家毒品使用与健康调查 (NSDUH) 报告称，12 岁及以上美国人的毒品使用量与前一年同期比较增长 3.8%。另据报导，21.4%的同侪在过去一年内使用过非法药物或滥用处方笺药。持续的疫情进一步加剧了毒品风险，某些地区年轻人的大麻消费量增加了四倍。毒品和酒精消费量的增加极大地促进了药物筛选市场的成长。

2023年药物筛选市场最大的地区是北美。预计亚太地区将成为预测期内药物筛选市场成长最快的地区。药物筛选市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 药物筛选市场特点

第三章药物筛选市场趋势与策略

第四章药物筛选市场－宏观经济情景

第五章 全球药物筛选市场规模及成长

  • 全球药物筛选市场的驱动与抑制因素
    • 市场驱动力
    • 市场抑制因素
  • 2018-2023年全球药物筛选市场规模实绩与成长
  • 2023-2028、2033年全球药物筛选市场规模及成长预测

第六章药物筛选市场区隔

  • 全球药物筛选市场，依产品细分，实绩与预测，2018-2023、2023-2028、2033
  • 快速检测装置
  • 消耗品
  • 其他产品
  • 全球药物筛选市场，依样本类型细分、实绩和预测，2018-2023、2023-2028、2033
  • 口腔液样本
  • 头髮样本
  • 尿液样本
  • 呼吸样本
  • 其他样品类型
  • 全球药物筛选市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033
  • 药物检测实验室
  • 职场
  • 刑事司法和执法
  • 医院
  • 戒毒治疗中心
  • 个人用户
  • 疼痛管理中心
  • 学校和大学

第 7 章药物筛选市场区域与国家分析

  • 全球药物筛选市场，按地区、实绩和预测，2018-2023、2023-2028、2033
  • 全球药物筛选市场，依国家、实绩及预测，2018-2023、2023-2028、2033

第八章亚太产品筛选市场

第九章 中国产品筛选市场

第十章 印度产品筛选市场

第十一章 日本产品筛选市场

第十二章 澳洲产品筛选市场

第十三章 印尼产品筛选市场

第14章韩国的产品筛选市场

第十五章 西欧产品筛选市场

第十六章英国产品筛选市场

第十七章 德国产品筛选市场

第十八章 法国产品筛选市场

第十九章 义大利产品筛选市场

第二十章 西班牙产品筛选市场

第二十一章 东欧产品筛选市场

第22章 俄罗斯产品筛选市场

第23章北美物体筛检市场

第24章美国产品筛选市场

第25章加拿大产品筛选市场

第26章南美洲产品筛选市场

第27章 巴西产品筛选市场

第28章 中东产品筛选市场

第29章 非洲产品筛选市场

第三十章药物筛选市场竞争形势及公司概况

  • 药物筛选市场竞争形势
  • 药物筛选市场公司概况
    • Laboratory Corporation
    • Quest Diagnostics Incorporated
    • Alere Inc.
    • OraSure Technologies Inc.
    • Alfa Scientific Designs Inc.

第三十一章 全球药物筛选市场竞争基准化分析

第32章全球药物筛选市场竞争仪錶板

第三十三章 药物筛选市场重大併购

第34章药物筛选市场未来展望及潜力分析

第35章附录

简介目录
Product Code: r9530

“Drug Screening Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug screening? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The drug screening market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Products: Rapid Testing Devices; Consumables; Other Products
  • 2) By Sample Type: Oral Fluid Sample; Hair Sample; Urine Sample; Breath Sample; Other Sample Types
  • 3) By End User: Drug Testing Laboratories; Workplaces; Criminal Justice and Law Enforcement Agencies; Hospitals; Drug Treatment Centers; Individual Users; Pain Management Centers; Schools and Colleges
  • Companies Mentioned: Laboratory Corporation; Quest Diagnostics Incorporated; Alere Inc.; OraSure Technologies Inc.; Alfa Scientific Designs Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Drug screening is an approach used for drug testing, specifically designed and optimized for clinical trials. It involves the analysis of blood, urine, hair, or saliva to detect the presence of chemicals, pollutants, and other illicit substances left in the body due to drug usage.

The main types of drug screening products include rapid testing devices, consumables, and other related items. Rapid testing devices are user-friendly screening tools that provide quicker results compared to traditional laboratory tests. Various samples, such as oral fluid, hair, urine, breath, and others, are used in drug screening. These screenings find applications in drug testing laboratories, workplaces, criminal justice and law enforcement, hospitals, drug treatment centers, individual users, pain management centers, schools, and colleges.

The drug screening market research report is one of a series of new reports from The Business Research Company that provides drug screening market statistics, including drug screening industry global market size, regional shares, competitors with a drug screening market share, detailed drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the drug screening industry. This drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug screening market size has grown rapidly in recent years. It will grow from $7.65 billion in 2023 to $8.79 billion in 2024 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to pharmaceutical drug testing, healthcare and clinical diagnostics, substance abuse treatment, research and development investments, and the increasing use of drug testing kits and devices.

The drug screening market size is expected to see rapid growth in the next few years. It will grow to $15.04 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to the legalization of cannabis and the opioid crisis, increasing sports events, point-of-care and rapid testing, evolving drug policies and regulations, growing workplace wellness and health programs, and international market expansion. Major trends in the forecast period include advanced drug detection technologies, telemedicine and remote testing, research and development investments, innovative drug testing kits and devices, and technological advancements in testing.

The growth of the drug screening market is expected to be driven by the increasing prevalence of drug and alcohol consumption. Drug addiction, a condition affecting both brain and behavior, leads to the inability to control the use of legal or illegal substances such as alcohol, marijuana, and nicotine. As drug and alcohol addiction rise, the associated health risks also increase, necessitating the demand for drug screening. In 2022, global concerns about drug and alcohol consumption persisted, with the National Survey on Drug Use and Health (NSDUH) reporting a 3.8% year-over-year increase in drug use among Americans aged 12 and over. The report also highlighted that 21.4% of people in the same age group had used illegal drugs or misused prescription drugs in the past year. The ongoing pandemic further exacerbated drug risks, with youth cannabis intake increasing up to four times in certain regions. The escalating drug and alcohol consumption significantly contribute to the growth of the drug screening market.

The growth trajectory of the drug screening market is further fueled by the increasing need for the treatment of substance abuse. Substance abuse, characterized by the harmful use of substances, necessitates the identification of compounds not normally present in the body through drug screening. The process involves a screening test followed by a confirmatory test to detect and validate the presence of substances. In June 2021, the United Nations Office on Drugs and Crime (UNODC) reported that over 275 million people worldwide used drugs in the last year, with more than 36 million suffering from drug use disorders. This growing demand for substance abuse treatment is a key driver propelling the growth of the drug screening market.

A notable trend in the drug screening market is the launch of innovative products. Major companies in this sector are actively developing and introducing innovative products to meet the rapidly growing industry demand and enhance their market positions. The COVID-19 pandemic prompted a shift in drug screening approaches, fostering innovation and new product development. Companies are striving to create more effective and widely applicable drug tests for laboratory use. For example, in September 2022, Sysmex Corporation, a Japan-based healthcare company, launched the UF-1500 Fully Automated Urine Particle Testing Analyzer. This innovative product, designed for urine sediment testing and screening, inherits the functionality and usability of the UF-5000 Fully Automated Urine Particle Analyzer while achieving a downsizing of the former model, exemplifying the trend of innovative product launches in the drug screening market.

Companies in the drug screening market are increasingly turning their attention to strategic partnerships and collaborations as a means to enhance their financial strength, fortify their product portfolios, and extend their geographical reach. Strategic collaborations involve agreements between two or more parties to jointly pursue agreed-upon objectives while maintaining their independence as organizations. An illustrative example occurred in December 2022 when PhoreMost Ltd., a UK-based biopharmaceutical company, and ThinkCyte K.K., a Japan-based biotechnology company, announced a strategic research partnership focused on advancing modern phenotypic drug screening through the application of artificial intelligence (AI). This collaboration integrates PhoreMost's SITESEEKER platform, designed to identify optimal new targets for future therapies, with ThinkCyte's Ghost Cytometry technology-a platform leveraging AI for cell characterization and sorting. By combining these innovative technologies, the partnership aims to improve the efficiency and effectiveness of phenotypic drug screening. The collaboration has the potential to identify novel drug targets and facilitate the development of effective therapeutics by leveraging AI and machine learning.

In April 2022, Saladax Biomedical, Inc., a US-based company specializing in the development, manufacturing, and marketing of assays providing rapid therapeutic drug levels, acquired a patent portfolio for antipsychotic drug testing and screening from Janssen Pharmaceutica NV, a Belgium-based pharmaceutical company. This acquisition enabled Saladax to develop tests compatible with chemistry analyzers commonly found in hospitals and a point-of-care instrument suitable for settings where centralized testing is not feasible. These tests address a significant unmet clinical need for patients with serious mental illness (SMI) by delivering rapid and actionable results to healthcare professionals. The collaboration exemplifies how strategic acquisitions contribute to addressing clinical needs and expanding the offerings in the drug screening market.

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Dragerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., LabOne Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

North America was the largest region in the drug screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The drug screening market consists of sales of testing kits, reagents, and other supplies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Drug Screening Market Characteristics

3. Drug Screening Market Trends And Strategies

4. Drug Screening Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drug Screening Market Size and Growth

  • 5.1. Global Drug Screening Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Screening Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Screening Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Screening Market Segmentation

  • 6.1. Global Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Rapid Testing Devices
  • Consumables
  • Other Products
  • 6.2. Global Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral Fluid Sample
  • Hair Sample
  • Urine Sample
  • Breath Sample
  • Other Sample Types
  • 6.3. Global Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Testing Laboratories
  • Workplaces
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges

7. Drug Screening Market Regional And Country Analysis

  • 7.1. Global Drug Screening Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Screening Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Screening Market

  • 8.1. Asia-Pacific Drug Screening Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Screening Market

  • 9.1. China Drug Screening Market Overview
  • 9.2. China Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Screening Market

  • 10.1. India Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Screening Market

  • 11.1. Japan Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Screening Market

  • 12.1. Australia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Screening Market

  • 13.1. Indonesia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Screening Market

  • 14.1. South Korea Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Screening Market

  • 15.1. Western Europe Drug Screening Market Overview
  • 15.2. Western Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Screening Market

  • 16.1. UK Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Screening Market

  • 17.1. Germany Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Screening Market

  • 18.5. France Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Screening Market

  • 19.9. Italy Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Screening Market

  • 20.13. Spain Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Screening Market

  • 21.1. Eastern Europe Drug Screening Market Overview
  • 21.2. Eastern Europe Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Screening Market

  • 22.1. Russia Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Screening Market

  • 23.1. North America Drug Screening Market Overview
  • 23.2. North America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Screening Market

  • 24.1. USA Drug Screening Market Overview
  • 24.2. USA Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Screening Market

  • 25.1. Canada Drug Screening Market Overview
  • 25.2. Canada Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Screening Market

  • 26.1. South America Drug Screening Market Overview
  • 26.2. South America Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Screening Market

  • 27.1. Brazil Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Screening Market

  • 28.1. Middle East Drug Screening Market Overview
  • 28.2. Middle East Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Screening Market

  • 29.1. Africa Drug Screening Market Overview
  • 29.2. Africa Drug Screening Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Screening Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Screening Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Screening Market Competitive Landscape And Company Profiles

  • 30.1. Drug Screening Market Competitive Landscape
  • 30.2. Drug Screening Market Company Profiles
    • 30.2.1. Laboratory Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Quest Diagnostics Incorporated
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Alere Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. OraSure Technologies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Alfa Scientific Designs Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Drug Screening Market Competitive Benchmarking

32. Global Drug Screening Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Drug Screening Market

34. Drug Screening Market Future Outlook and Potential Analysis

  • 34.1 Drug Screening Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Drug Screening Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Drug Screening Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer